HER2 Support Group Forums

HER2 Support Group Forums (https://her2support.org/vbulletin/index.php)
-   General Cancer News (https://her2support.org/vbulletin/forumdisplay.php?f=45)
-   -   Nektar completes enrollment in BEACON trial of NKTR-102 in patients with metastatic b (https://her2support.org/vbulletin/showthread.php?t=58730)

News 07-31-2013 03:17 AM
Nektar completes enrollment in BEACON trial of NKTR-102 in patients with metastatic b
 
Nektar Therapeutics (NASDAQ: NKTR) today announced that enrollment is complete in the pivotal clinical study of etirinotecan pegol (NKTR-102) in patients with metastatic breast cancer.

More...


All times are GMT -7. The time now is 08:42 PM.

Powered by vBulletin® Version 3.8.7
Copyright ©2000 - 2026, vBulletin Solutions, Inc.
Copyright HER2 Support Group 2007 - 2021